WHWK Stock Analysis: Buy, Sell, or Hold?
WHWK - Whitehawk Therapeutics, Inc. Common Stock
$4.34
0.16 (3.83%)
▲
5d:
-9.21%
30d:
+4.33%
90d:
+33.54%
HOLD
LOW Confidence
Analysis Updated: Jun 3, 2026 12:00 AM ET
Earnings: May 14, 2026
0d
Get Alerted When WHWK Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: WHWK shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: WHWK shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: WHWK is currently trading at $4.34, which is considered fair relative to its 30-day fair value range of $3.98 to $4.66.
Technical Outlook: Technically, WHWK is in a strong uptrend. Immediate support is located at $3.91, while resistance sits at $5.21. The stock is showing strong short-term momentum, up 3.8% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $6.50 (+49.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, WHWK is in a strong uptrend. Immediate support is located at $3.91, while resistance sits at $5.21. The stock is showing strong short-term momentum, up 3.8% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $6.50 (+49.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$3.98 -
$4.66
Company Quality Score
54/100
(HOLD)
Options IV Signal
45th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
77.9%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Options fairly priced (IV 45th percentile)
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.8%)
- BULLISH: Trading 49.8% below Wall St target ($6.50)
- CAUTION: Recommendation downgraded due to -9.2% 5-day decline
Trading Range Analysis
30-Day Trading Range
$3.98 -
$4.66
Current vs Trading Range
FAIR
Expected Move (7 Days)
±$0.68
(15.6%)
Support & Resistance Levels
Support Level
$3.91
Resistance Level
$5.21
Current Trend
Strong Uptrend
Technical data as of
Jun 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-3.24
Wall Street Target
$6.50
(+49.8%)
Revenue Growth (YoY)
-100.0%
Profit Margin
-288.3%
Share & Embed Analysis
Last updated: June 03, 2026 5:09 PM ET
Data refreshes hourly during market hours. Next update: 6:09 PM
Data refreshes hourly during market hours. Next update: 6:09 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is WHWK showing a specific setup today?
Insider Activity (6 Months)
0
Buys
14
Sells
Net
INSIDERS SELLING
Recent Transactions
Scott M Giacobello
SELL
141600 shares
2026-04-16
Scott M Giacobello
SELL
77000 shares
2026-04-15
Bryan Ball
SELL
92460 shares
2026-04-14
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$27 | 54 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$412 | 53 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$270 | 55 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$28 | 62 BUY |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$108 | 56 HOLD |